Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,789 | -24,018 | -41,009 | 875 | -6,388 |
| Depreciation Amortization | 1,865 | 1,777 | 2,333 | 2,744 | 3,077 |
| Accounts receivable | -2,368 | 1,047 | -966 | 6,236 | -2,489 |
| Accounts payable and accrued liabilities | 8,185 | -2,769 | 181 | -7,591 | 4,994 |
| Other Working Capital | 4,075 | -2,693 | -1,662 | -5,761 | -914 |
| Other Operating Activity | 15,841 | 15,099 | 40,202 | 16,735 | 25,475 |
| Operating Cash Flow | $-4,191 | $-11,557 | $-921 | $13,238 | $23,755 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -405 | -803 | -1,101 | -1,812 | -3,208 |
| Net Acquisitions | -12,904 | 28,160 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -700 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -9,659 | -1,901 | -4,876 | -6,879 | -6,990 |
| Other Investing Activity | -9,659 | -1,901 | -4,876 | -6,879 | -6,990 |
| Investing Cash Flow | $-22,968 | $24,756 | $-5,977 | $-8,691 | $-10,198 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,520 |
| Debt Issued | 30,176 | 5,000 | 100,015 | N/A | N/A |
| Debt Repayment | N/A | -10,050 | -34,500 | N/A | N/A |
| Common Stock Issued | 7,391 | N/A | 25,399 | N/A | N/A |
| Other Financing Activity | -8,757 | -10,992 | -103,236 | -6,019 | -7,236 |
| Financing Cash Flow | $28,810 | $-16,042 | $-12,322 | $-6,019 | $-2,716 |
| Exchange Rate Effect | -175 | -44 | -112 | 55 | 86 |
| Beginning Cash Position | 3,691 | 6,578 | 25,910 | 27,327 | 16,400 |
| End Cash Position | 5,167 | 3,691 | 6,578 | 25,910 | 27,327 |
| Net Cash Flow | $1,476 | $-2,887 | $-19,332 | $-1,417 | $10,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,191 | -11,557 | -921 | 13,238 | 23,755 |
| Capital Expenditure | -405 | -803 | -1,101 | -1,812 | -3,178 |
| Free Cash Flow | -4,596 | -12,360 | -2,022 | 11,426 | 20,577 |